Avanos Medical (AVNS) Return on Capital Employed (2014 - 2026)
Avanos Medical (AVNS) reported Return on Capital Employed of 6.77% for Q1 2026, up 3246.0% on a YoY basis from 0.2% in Q1 2025, and little changed sequentially from 6.8% in Q4 2025.
Avanos Medical (AVNS) Return on Capital Employed (2014 - 2026) Analysis & Trends
Avanos Medical (AVNS) has 13 years of Return on Capital Employed data on file, last reported at 6.77% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 3246.0% year-over-year to 6.77%; the trailing twelve-month figure through Mar 2026 stood at 6.77% (up 3246.0% YoY), and the FY2025 full-year result was 6.49%, up 2502.0% from the prior year.
- Return on Capital Employed held at 6.77% in Q1 2026, from 6.8% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 3.03% in Q4 2022 to a low of 53.3% in Q3 2025.
- A 5-year average of 10.39% and a median of 0.28% in 2023 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed sank 5562 bps in 2025 and surged 3246 bps in 2026, its largest moves.
- Tracing AVNS's Return on Capital Employed over 5 years: stood at 3.03% in 2022, then sank by 91 bps to 0.28% in 2023, then sank by 11320 bps to 31.97% in 2024, then soared by 79 bps to 6.8% in 2025, then grew by 0 bps to 6.77% in 2026.
- Business Quant data shows AVNS's Return on Capital Employed at 6.77% in Q1 2026, 6.8% in Q4 2025, and 53.3% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 24.24% |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | 9.30% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 8.38% |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn | -6.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.77% |
| Dec 31, 2025 | -6.80% |
| Sep 30, 2025 | -53.30% |
| Jun 30, 2025 | -50.14% |
| Mar 31, 2025 | -39.23% |
| Dec 31, 2024 | -31.97% |
| Sep 30, 2024 | 2.32% |
| Jun 30, 2024 | 1.56% |
| Mar 31, 2024 | 0.97% |
| Dec 31, 2023 | 0.28% |
| Sep 30, 2023 | 0.63% |
| Jun 30, 2023 | 1.38% |
| Mar 31, 2023 | 2.08% |
| Dec 31, 2022 | 3.03% |
| Sep 30, 2022 | 0.57% |
| Jun 30, 2022 | -0.02% |
| Mar 31, 2022 | -1.16% |
| Dec 31, 2021 | -2.65% |
| Sep 30, 2021 | -4.20% |
| Jun 30, 2021 | -4.44% |